Imidazo[1,2-A]pyridine and pyrazolo[2,3-A]pyridine derivatives
AssigneeAstraZeneca AB
InventorsAndrew Peter Thomas, Gloria Anne Breault, John Franklin Beattie, Phillip John Jewsbury
Life of this patent
Estimating the term…
Loading patent…
AssigneeAstraZeneca AB
InventorsAndrew Peter Thomas, Gloria Anne Breault, John Franklin Beattie, Phillip John Jewsbury
Estimating the term…
A compound of formula (I) wherein Ring A is imidazol[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl; R2 is as defined within; m is 0-5; wherein the values of R2 may be the same or different; R1 is as defined within; n is 0 to 2, wherein the values of R1 may be the same or different; Ring B is phenyl or phenyl fused to a C5-7cycloalkyl ring; R3 is as defined within; p is 0-4; wherein the values of R3 may be the same or different; R4 is as defined within; q is 0-2; wherein the values of R4 may be the same or different; and wherein p+q≦5; or a pharmaceutically acceptable salt or an in vivo hydrolyzable ester thereof is described. The use of compounds of formula (I) in the inhibition of cell cycle kinases CDK2, CDK4, and CDK6 are also described. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are detailed.
A compound of formula (I):
A compound of formula (I) selected from:
Dependencies are inferred from the claim text.